Industry News: Study Finds that Pancreatic Cancer Patient Survival Doubled with High Dose of Vitamin C
A recent study from the University of Iowa suggests that high-dose intravenous vitamin C, when combined with chemotherapy, may improve survival rates for patients with late-stage metastatic pancreatic cancer. In this phase 2 trial, patients receiving 75 grams of vitamin C three times a week alongside chemotherapy experienced an increase in overall survival from eight to sixteen months, and progression-free survival from four to six months.
